Tumor Markers

ARUP Laboratories’ offers a large menu of established cancer biomarkers, including traditional ones such as CEA, CA-GI (CA 19-9) and CA 27.29. Circulating tumor cell counting is available for three clinical indications, and the MesoMark mesothelioma test is offered. ARUP now has available a blood-based colorectal cancer screening test based on the Septin 9 methylated DNA biomarker.
  • Vice President, Technology Assessment and Licensing
    Director, PharmaDx Program
    Dr. Heichman is an adjunct associate professor at the University of Utah School of Medicine. Her role at ARUP as the director of the PharmaDx program involves developing and managing collaborations with pharmaceutical companies. The PharmaDx team recently received FDA approval of two companion diagnostic tests developed and validated for use with the drug Gleevec. Dr. Heichman holds an AB in genetics from UC Berkeley and a PhD in biological chemistry from the UCLA School of Medicine. She trained as a postdoctoral fellow in the field of cycle control at the Fred Hutchinson Cancer Research Center in Seattle.